| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/10/2006 | CN1771248A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771246A Novel synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-non-ene-4-one |
| 05/10/2006 | CN1771244A Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 05/10/2006 | CN1771237A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771032A Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 05/10/2006 | CN1769284A Substituted 1H-indole-2-ketone compound and its preparation method and uses |
| 05/10/2006 | CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/10/2006 | CN1769274A Pyrazinone protease inhibitors |
| 05/10/2006 | CN1255401C Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 05/10/2006 | CN1255380C Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/09/2006 | US7041836 Antibiotic compounds |
| 05/09/2006 | US7041834 alkylamination of N-methylcarbazol-5-one at the 6-position in the presence of formaldehyde, a secondary amine, and a desiccant; deamination and coupling of 2-methylimidazole at the 1-position; reaction time less than three hours |
| 05/09/2006 | US7041832 Processes for preparing losartan and losartan potassium |
| 05/09/2006 | US7041828 Phenyl-substituted imidazopyridines |
| 05/09/2006 | US7041827 Phenyl-substituted imidazopyridines |
| 05/09/2006 | US7041825 Additive compound for curing halogenated polymers |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041686 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 05/09/2006 | US7041684 4-[2-Hydroxy-3-([4-(5-carbamoyl-2-pyridyloxy)phenyl]-2-methylpropylamino)propoxy]carbazole and salts;treating obesity; antidiabetic agent for non-insulin dependent diabetes (Type II); |
| 05/09/2006 | US7041672 Substituted aryl 1, 4-pyrazine derivatives |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 05/09/2006 | US7041667 CCR5 modulators |
| 05/09/2006 | US7041663 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/09/2006 | US7041354 Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer |
| 05/09/2006 | US7041303 Use of moxonidine for postmyocardial infarction treatment |
| 05/09/2006 | CA2262668C Inhibitors of cathepsin k |
| 05/09/2006 | CA2257646C Benzo[g]quinoline derivatives |
| 05/09/2006 | CA2192788C Optical brightening agents |
| 05/04/2006 | WO2006047528A2 Pyrazolobenzamides and derivatives as factor xa inhibitors |
| 05/04/2006 | WO2006047492A2 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 05/04/2006 | WO2006046043A1 Process for the preparation of irbesartan hydrochloride |
| 05/04/2006 | WO2006023573A3 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 05/04/2006 | WO2006023231A3 Fluorescent metal ion indicators with large stokes shift |
| 05/04/2006 | WO2006021454A3 Pyrimidine derivatives |
| 05/04/2006 | WO2005123718A3 Benzimidazolone carboxylic acid derivatives |
| 05/04/2006 | WO2005109987A3 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 05/04/2006 | WO2005049581A8 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors |
| 05/04/2006 | WO2005025681A3 A system for and a method of manufacturing personal golf putters |
| 05/04/2006 | US20060094883 high yields, low cost process; easy solvent extraction; nontoxic, safe, environmentally friendly, low boiling point organic solvents; 1,7'-dimethyl-2'-propyl-1H,3'H-[2,5']bibenzoimidazolyl is reacted with 4'bromomethyl-biphenyl-2-carboxylic acid alkyl ester; industrial scale; hydrolysis |
| 05/04/2006 | US20060094881 Methods of preparing indazole compounds |
| 05/04/2006 | US20060094879 5-{4-[1-(2-Ethoxyethyl)-1H-indol-3-yl]piperidin-1-ylmethyl}-2-methoxybenzoic acid; histamine H1 antagonists; bronchial dialtors; asthma; allergic rhinitis; conjunctivitis; dermatitis; urticaria; selective antiallergic effects so less side effect reduction and lower dosage |
| 05/04/2006 | US20060094763 Polymorphic forms of 6-[2-(methylcarbomoyl) phenyl sulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole |
| 05/04/2006 | US20060094757 Substantially pure cilostazol and processes for making same |
| 05/04/2006 | US20060094756 combining 6-hydroxy-3,4-dihydroquinolinone and an alkali metal carbonate; removing water using molecular sieves; adding 1-cyclohexyl-5-(4-halobutyl)-tetrazole; and recovering cilostazol. |
| 05/04/2006 | US20060094743 Isoquinoline compounds and medicinal use thereof |
| 05/04/2006 | US20060094735 Compounds for cell proliferation, anticancer agents, kinesin inbiitors |
| 05/04/2006 | US20060094732 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 05/04/2006 | US20060094730 Water-soluble thalidomine derivatives |
| 05/04/2006 | US20060094726 Quinoline derivatives as nk-2 and nk-3 receptor antagonists |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094719 Tetralin histamine-3 receptor antagonists |
| 05/04/2006 | US20060094711 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 05/04/2006 | US20060094710 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | US20060094694 Heterocyclic compounds and thrombopoietin receptor activators |
| 05/04/2006 | CA2585138A1 Process for the preparation of irbesartan hydrochloride |
| 05/04/2006 | CA2584241A1 Cgrp receptor antagonists |
| 05/04/2006 | CA2584167A1 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 05/03/2006 | EP1652847A1 Quinoline and quinazoline derivatives for the treatment of tumors |
| 05/03/2006 | EP1651631A1 Bicyclic imidazol derivatives against flaviviridae |
| 05/03/2006 | EP1651622A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 05/03/2006 | EP1651621A1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 05/03/2006 | EP1651620A2 Piperazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651612A1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/03/2006 | EP1651611A2 Benzimidazole c-2 heterocycles as kinase inhibitors |
| 05/03/2006 | EP1651610A1 Quinoline derivates and their use in therapy |
| 05/03/2006 | EP1651599A1 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1651229A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 05/03/2006 | EP1651219A2 Aripiprazole and haloperidol pamoate salts |
| 05/03/2006 | EP1651214A2 Benzimidazole derivatives as mek inhibitors |
| 05/03/2006 | EP1515955A4 Chemical process |
| 05/03/2006 | EP1444224B1 3-substituted oxindole beta-3 agonists |
| 05/03/2006 | EP1444200B1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1227805B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/03/2006 | EP1099692B1 N,n-substituted cyclic amine derivatives |
| 05/03/2006 | EP1074542B1 Sulfonamide-containing indole compounds |
| 05/03/2006 | EP0937069B1 Piperazino derivatives as neurokinin antagonists |
| 05/03/2006 | EP0672042B1 Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 05/03/2006 | CN1768053A Pyrazole compounds. |
| 05/03/2006 | CN1768052A Substituted pyrazole compounds |
| 05/03/2006 | CN1768051A Substituted pyrazoles |
| 05/03/2006 | CN1768044A Process for manufacture of telmisartan |
| 05/03/2006 | CN1768043A 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders. |
| 05/03/2006 | CN1768042A Process for producing acrylonitrile compound |
| 05/03/2006 | CN1765896A Novel preparation method of ramosetron hydrochloride |
| 05/03/2006 | CN1254474C Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 05/02/2006 | US7038060 Synthesis of 2-butyl-3-(2′-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-non-ene-4-one |
| 05/02/2006 | US7038057 Alkylation, acylation |
| 05/02/2006 | US7037931 CCK-1 receptor modulators |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037917 Nitrogen compounds such as 4-((4-amino-5-bromo-6-(4-cyano-2,6-dimethylphenyloxy)-2 -pyrimidinyl)amino)benzonitrile, used as protease inhibitors for prophylaxis of viral diseases |
| 05/02/2006 | US7037916 Antiinflammatory agents; antiarthritic agents; anticholesterol agents; cardiovascular disorders; muscle and skin disorders |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 05/02/2006 | US7037908 HIV integrase inhibitors |
| 05/02/2006 | CA2173974C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 04/27/2006 | WO2006044955A1 Phosphodiesterase 4 inhibitors |